Related references
Note: Only part of the references are listed.A Serum Protein Signature Associated with Outcome after Anti-PD-1 Therapy in Metastatic Melanoma
Jeffrey S. Weber et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Diseases of complement dysregulation-an overview
Edwin K. S. Wong et al.
SEMINARS IN IMMUNOPATHOLOGY (2018)
Complement as a Biological Tool to Control Tumor Growth
Paolo Macor et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer
Yang Su et al.
JCI INSIGHT (2018)
The complement system in cancer: Ambivalence between tumour destruction and promotion
Srinivas Mamidi et al.
IMMUNOBIOLOGY (2017)
The role of the complement system in cancer
Vahid Afshar-Kharghan
JOURNAL OF CLINICAL INVESTIGATION (2017)
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
Caner Saygin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The role of complement inhibitors beyond controlling inflammation
A. M. Blom
JOURNAL OF INTERNAL MEDICINE (2017)
TCR-stimulated changes in cell surface CD46 expression generate type 1 regulatory T cells
Siobhan Ni Choileain et al.
SCIENCE SIGNALING (2017)
Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma
Ze-Wu Meng et al.
TUMOR BIOLOGY (2017)
CD55 and CD59 expression protects HER2-overexpressing breast cancer cells from trastuzumab-induced complement-dependent cytotoxicity
Yu Wang et al.
ONCOLOGY LETTERS (2017)
A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis
Daniel Ajona et al.
CANCER DISCOVERY (2017)
TCR-stimulated changes in cell surface CD46 expression generate type 1 regulatory T cells
Siobhan Ni Choileain et al.
SCIENCE SIGNALING (2017)
Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade
Haoran Zha et al.
ONCOIMMUNOLOGY (2017)
Inhibiting C5a/C5aR axis reduces myeloid-derived suppressor cells and enhances PD-1 blockade therapy in lung cancer
Sherven Sharma et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Overexpression of CD55 from Barrett's esophagus is associated with esophageal adenocarcinoma risk
Takahisa Murao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
CD28 Costimulation: From Mechanism to Therapy
Jonathan H. Esensten et al.
IMMUNITY (2016)
Cytotoxic activity against human neuroblastoma and melanoma cells mediated by IgM antibodies derived from peripheral blood of healthy donors
Satish Kumar Devarapu et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells
Daniel W. Sherbenou et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
Roberta Bulla et al.
NATURE COMMUNICATIONS (2016)
Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression
Yu Wang et al.
CANCER DISCOVERY (2016)
Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy
Yoshio Nakamura et al.
ONCOTARGET (2016)
Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways
Ling-Ling An et al.
SCIENTIFIC REPORTS (2016)
Monocyte: T-cell interaction regulates human T-cell activation through a CD28/CD46 crosstalk
Lauren Charron et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Immunohistochemical Expression and Prognostic Significance of CD97 and its Ligand DAF in Human Cervical Squamous Cell Carcinoma
Ying He et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2015)
The role of complement factor C3 in lipid metabolism
Andreea Barbu et al.
MOLECULAR IMMUNOLOGY (2015)
Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer
Mariana Diaz-Zaagoza et al.
ONCOLOGY REPORTS (2015)
Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells
Srinivas Mamidi et al.
ONCOIMMUNOLOGY (2015)
Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer
Zheng He et al.
ONCOLOGY LETTERS (2015)
Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
Surya Kumari Vadrevu et al.
CANCER RESEARCH (2014)
The Complement Inhibitor CD59 Regulates Insulin Secretion by Modulating Exocytotic Events
Ulrika Krus et al.
CELL METABOLISM (2014)
Distinct Roles of the Anaphylatoxins C3a and C5a in Dendritic Cell-Mediated Allergic Asthma
Carsten Engelke et al.
JOURNAL OF IMMUNOLOGY (2014)
Increased CD59 protein expression is associated with the outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP
Guoqi Song et al.
MEDICAL ONCOLOGY (2014)
Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma
Zejun Lu et al.
ONCOLOGY REPORTS (2014)
CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy
Yoram Nevo et al.
BLOOD (2013)
Wavelet feature extraction and genetic algorithm for biomarker detection in colorectal cancer data
Yihui Liu et al.
KNOWLEDGE-BASED SYSTEMS (2013)
Transient Removal of CD46 Is Safe and Increases B-cell Depletion by Rituximab in CD46 Transgenic Mice and Macaques
Ines Beyer et al.
MOLECULAR THERAPY (2013)
Overview of Complement Activation and Regulation
Marina Noris et al.
SEMINARS IN NEPHROLOGY (2013)
Complement Receptor 1 Expression in Peripheral Blood Mononuclear Cells and the Association with Clinicopathological Features And Prognosis of Nasopharyngeal Carcinoma
Jian-Rong He et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy
S. Bellone et al.
BRITISH JOURNAL OF CANCER (2012)
Complement and non-complement activating functions of C1q: A prototypical innate immune molecule
Annapurna Nayak et al.
INNATE IMMUNITY (2012)
Immunohistochemical Expression and Prognostic Value of CD97 and Its Ligand CD55 in Primary Gallbladder Carcinoma
Jinsheng Wu et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Interactions between coagulation and complement-their role in inflammation
Katerina Oikonomopoulou et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
CD3/CD46-MEDIATED GENERATION OF IL-10-SECRETING T CELLS IS DEFECTIVE IN RHEUMATOID ARTHRITIS
Gaelle Le Friec et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Decay-accelerating factor regulates T-cell immunity in the context of inflammation by influencing costimulatory molecule expression on antigen-presenting cells
Chongyun Fang et al.
BLOOD (2011)
Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
Weiguo Hu et al.
CANCER RESEARCH (2011)
Application of a novel inhibitor of human CD59 for the enhancement of complement-dependent cytolysis on cancer cells
Tao You et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
The effects of CD59 gene as a target gene on breast cancer cells
Bing Li et al.
CELLULAR IMMUNOLOGY (2011)
rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia
Xiaowen Ge et al.
CLINICAL CANCER RESEARCH (2011)
CD46 Expression is an Unfavorable Prognostic Factor in Breast Cancer Cases
Adam Maciejczyk et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis
Harald F. Langer et al.
BLOOD (2010)
CD46 Engagement on Human CD4+ T Cells Produces T Regulatory Type 1-Like Regulation of Antimycobacterial T Cell Responses
Steven M. Truscott et al.
INFECTION AND IMMUNITY (2010)
The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma
Shao-Liang Han et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
A Defect of CD4+CD25+ Regulatory T Cells in Inducing Interleukin-10 Production From CD4+T Cells Under CD46 Costimulation in Asthma Patients
Ya-Qing Xu et al.
JOURNAL OF ASTHMA (2010)
Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells
John Cardone et al.
NATURE IMMUNOLOGY (2010)
Complement in multiple sclerosis: its role in disease and potential as a biomarker
G. Ingram et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
CD59 Blockade Enhances Antigen-Specific CD4+ T Cell Responses in Humans: A New Target for Cancer Immunotherapy?
Baalasubramanian Sivasankar et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Complement Receptor 1 (A3650G RsaI and Intron 27 HindIII) Polymorphisms and Risk of Gallbladder Cancer in North Indian Population
A. Srivastava et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Complement regulators and inhibitory proteins
Peter F. Zipfel et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Prognostic significance of CD55 expression in breast cancer
Jun-ichiro Ikeda et al.
CLINICAL CANCER RESEARCH (2008)
Role of complement and complement regulators in the removal of apoptotic cells
L. A. Trouw et al.
MOLECULAR IMMUNOLOGY (2008)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
Complement evasion by human pathogens
John D. Lambris et al.
NATURE REVIEWS MICROBIOLOGY (2008)
The role of the complement anaphylatoxins in the recruitment of eosinophils
Richard G. DiScipio et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Down-regulation of CD55 and CD46 expression by anti-sense phosphorothioate oligonucleotides (S-ODNs) sensitizes tumour cells to complement attack
S. Zell et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice
Chongyun Fang et al.
JOURNAL OF IMMUNOLOGY (2007)
Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity
Ralf Buettner et al.
MOLECULAR CANCER RESEARCH (2007)
Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55
Rachel J. M. Abbott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Complement susceptibility in glutamine deprived breast cancer cells
Bradley S. Ellison et al.
CELL DIVISION (2007)
Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
Anne L. Astier et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients
NFS Watson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Costimulation via CD55 on human CD4+ T cells mediated by CD97
Melania Capasso et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo
Robert D. Loberg et al.
NEOPLASIA (2006)
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59
F Ziller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Decay-accelerating factor modulates induction of T cell immunity
PS Heeger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Antibodies against tumor cell glycolipids and proteins, but not mucins, mediate complement-dependent cytotoxicity
G Ragupathi et al.
JOURNAL OF IMMUNOLOGY (2005)
Natural serum IgM maintains immunological homeostasis and prevents autoimmunity
JJ Manson et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo
JN Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy
CL Xu et al.
PROSTATE (2005)
CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes
A Sánchez et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
CD46: expanding beyond complement regulation
RC Riley-Vargas et al.
TRENDS IN IMMUNOLOGY (2004)
Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: A systematic review and meta-analysis
WH Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum:: a meta-analysis -: art. no. 28
A González-Pérez et al.
BMC CANCER (2003)
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients
LG Durrant et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors
Z Fishelson et al.
MOLECULAR IMMUNOLOGY (2003)
Loss of CD59 expression in breast tumours correlates with poor survival
Z Madjd et al.
JOURNAL OF PATHOLOGY (2003)
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid
N Donin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype
C Kemper et al.
NATURE (2003)
Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues
M Steinert et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies
KA Gelderman et al.
LABORATORY INVESTIGATION (2002)
CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9
I Farkas et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Regulation of the new coexpressed CD55 (decay-accelerating factor) receptor on stomach carcinoma cells involved in antibody SC-1-induced apoptosis
F Hensel et al.
LABORATORY INVESTIGATION (2001)
K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement
K Jurianz et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Epidermal growth factor induces expression of decay-accelerating factor in human colonic cancer cells via the mitogen-activated protein kinase pathway
K Takeuchi et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b
XB Qin et al.
MAMMALIAN GENOME (2001)
Role of natural and immune IgM antibodies in immune responses
M Boes
MOLECULAR IMMUNOLOGY (2000)
Expression of complement regulatory proteins - CD 35, CD 46, CD 55, and CD 59 - in benign and malignant endometrial tissue
KP Murray et al.
GYNECOLOGIC ONCOLOGY (2000)
Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies
D Guc et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
Share Paper
